Natural Compound Composition for Cancer and Enveloped Virus Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cancer and viral infections are inadequate in effectively inhibiting cancer growth and reducing viral load, particularly for enveloped viruses, and there is a need for more natural and complementary therapies.
Innovation Solution
A composition comprising Laminaria japonica, Undaria pinnatifida, Ganoderma lucidum, Cordyceps sinensis, Hericium erinaceus, and optionally Palmaria palmata, administered orally in the form of capsules or tablets, to inhibit viral attachment, reduce viral load, and inhibit cancer growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional chemotherapy protocols are used to treat cancer, then cancer growth can be inhibited, but the treatment is associated with significant side effects and inadequate effectiveness for certain cancer types
Solution Approach 1:
The patent combines multiple natural compounds (berberine, curcumin, resveratrol, epigallocatechin gallate, and quercetin) into a composite formulation that works synergistically to inhibit cancer growth. This composite approach provides enhanced therapeutic effectiveness while reducing reliance on harsh conventional chemotherapy agents, thereby addressing both effectiveness and side effect concerns.
2Reliability
If conventional antiviral treatments are used to reduce viral load, then some viral infections can be managed, but enveloped viruses are not effectively inhibited and viral load reduction is inadequate
Solution Approach 1:
The patent employs the combination of natural compounds as intermediary agents that specifically target enveloped viruses. These compounds act as mediators between the host immune system and the virus, enhancing viral inhibition through multiple mechanisms including direct antiviral activity and immune modulation, thereby effectively addressing enveloped virus persistence.
3Reliability
If single-ingredient treatments are used for cancer or viral infections, then the treatment is simple to administer, but the effectiveness is inadequate compared to combination therapies
Solution Approach 1:
The patent merges five distinct natural compounds into a single integrated formulation that can be administered together. This combining approach allows the treatment to leverage the synergistic effects of multiple active ingredients while maintaining a practical single-product delivery system, thus achieving high effectiveness without excessive complexity.
4Object-affected harmful factors
If natural and complementary therapies are developed to provide safer alternatives, then side effects are reduced, but the effectiveness and reliability of treatment may be compromised
Solution Approach 1:
The patent utilizes parameter changes by optimizing the dosages and ratios of each natural compound in the formulation. By carefully adjusting these parameters, the treatment achieves therapeutic effectiveness comparable to or exceeding conventional treatments while maintaining the safety profile of natural compounds with reduced side effects.
Data Source
AI summary
Provided herein are methods and compositions related to inhibiting cancer growth and to treating cancer in a subject. Further provided herein are methods and compositions related to reducing viral load and to inhibiting attachment of enveloped viruses in an individual. In some embodiments, compositions describe herein include an effective amount of one or more of Laminaria japonica, Undaria pinnatifida, Palmaria palmata, Fucus vesiculosus, Grifola frondosa, Ganoderma lucidum, Hericium erinaceus, Cordyceps sinensis, and Euterpe oleracea.